These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9234003)

  • 1. Use of implantable insulin pumps: the EVADIAC position. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases). Evaluation dans le Diabete du Traitement par Implants Actifs.
    Lassmann-Vague V; Guerci B; Hanaire-Broutin H; Pinget M; Renard E; Selam JL; Vague P
    Diabetes Metab; 1997 Jun; 23(3):234-50. PubMed ID: 9234003
    [No Abstract]   [Full Text] [Related]  

  • 2. Local adverse events associated with long-term treatment by implantable insulin pumps. The French EVADIAC Study Group experience. Evaluation dans le Diabète du Traitement par Implants Actifs.
    Bélicar P; Lassmann-Vague V
    Diabetes Care; 1998 Feb; 21(2):325-6. PubMed ID: 9540008
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of in vivo stability of a new insulin preparation for implantable insulin pumps. A randomized multicenter prospective trial. EVADIAC Group. Evaluation Dans le diabète du Traitement par Implants Actifs.
    Boivin S; Belicar P; Melki V
    Diabetes Care; 1999 Dec; 22(12):2089-90. PubMed ID: 10587853
    [No Abstract]   [Full Text] [Related]  

  • 4. Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM. A multicenter study. The EVADIAC Study Group. Evaluation dans le Diabète du Traitement par Implants Actifs.
    Hanaire-Broutin H; Broussolle C; Jeandidier N; Renard E; Guerci B; Haardt MJ; Lassmann-Vague V
    Diabetes Care; 1995 Mar; 18(3):388-92. PubMed ID: 7555483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of a newly designed compliant side port catheter for an insulin implantable pump: the EVADIAC experience. Evaluation dans le Diabete du Traitement par Implants Actifs.
    Gin H; Melki V; Guerci B; Catargi B;
    Diabetes Care; 2001 Jan; 24(1):175. PubMed ID: 11194228
    [No Abstract]   [Full Text] [Related]  

  • 6. [Developments in insulin pumps and recommendations for best practices].
    Mantovan I
    Soins; 2010 Dec; (751):30-1. PubMed ID: 21298937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations regarding obesity surgery.
    Laville M; Romon M; Chavrier G; Guy-Grand B; Krempf M; Chevallier JM; Marmuse JP; Basdevant A
    Obes Surg; 2005; 15(10):1476-80. PubMed ID: 16354530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of insulin pumps, even in adolescent use, depends on thorough patient selection, evaluation, and education.
    Exelbert LL
    Pediatrics; 2008 Sep; 122(3):682; author reply 682-3. PubMed ID: 18762546
    [No Abstract]   [Full Text] [Related]  

  • 9. Implantable insulin pumps. A position statement about their clinical use.
    Renard E; Schaepelynck-Bélicar P;
    Diabetes Metab; 2007 Apr; 33(2):158-66. PubMed ID: 17300973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical management of a diabetic patient treated with an implantable insulin pump].
    Selam JL; Haardt MJ; Bethoux JP; Slama G
    Diabete Metab; 1991; 17(6):545-8. PubMed ID: 1809602
    [No Abstract]   [Full Text] [Related]  

  • 11. [Insulin from cow and "mad cow". Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases)].
    Massabie P
    Diabetes Metab; 1997 Sep; 23(4):360-2. PubMed ID: 9432279
    [No Abstract]   [Full Text] [Related]  

  • 12. [Arteriopathy of the lower limb in the diabetic patient. Recommendations of ALFEDIAM (French Language Association for the study of Diabetes and Metabolic Diseases)].
    Benhamou AC; Dadon M; Emmerich J; Fontaine P; Got I; Guillausseau PJ; Pernes J; Priollet P
    Diabetes Metab; 1997 Dec; 23(6):541-8. PubMed ID: 9496563
    [No Abstract]   [Full Text] [Related]  

  • 13. [Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion].
    Szypowska A; Pańkowska E; Lipka M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):45-50. PubMed ID: 16704861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory insulin infusion pumps.
    Health Devices; 1988 Dec; 17(12):365-6. PubMed ID: 3078914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2009 resource guide. Insulin pumps. Some people with diabetes use wearable pumps to provide their insulin.
    Diabetes Forecast; 2009 Jan; 62(1):49-52. PubMed ID: 19445086
    [No Abstract]   [Full Text] [Related]  

  • 16. [With respect to the SFC/ALFEDIAM (French Cardiology Society/French-speaking Association for the Study of Diabetes and Metabolic Diseases) guidelines on the management of diabetes].
    Danchin N
    Arch Mal Coeur Vaiss; 2004 Mar; 97(3):185-6. PubMed ID: 15106740
    [No Abstract]   [Full Text] [Related]  

  • 17. [Personal insulin pumps--from experiment research till recommended method of diabetes treatment].
    Mozdzan M; Ruxer J; Loba J
    Pol Merkur Lekarski; 2005 Oct; 19(112):577-9. PubMed ID: 16379330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status and future of implantable insulin pumps for the treatment of diabetes.
    Catargi B
    Expert Rev Med Devices; 2004 Nov; 1(2):181-5. PubMed ID: 16293038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin pumps and glucose regulation.
    Thompson JS; Duckworth WC
    World J Surg; 2001 Apr; 25(4):523-6. PubMed ID: 11344407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P
    Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.